BioMOBIUS™ Research Platform Allows Sophisticated Technology Solutions for Biomedical Research

TRIL (Technology Research for Independent Living) CentreTRIL (Technology Research for Independent Living) Centre launched the BioMOBIUS™ Research Platform, an open shareable technology platform, which allows researcher to rapidly develop sophisticated technology solutions for biomedical research. This platform helps researchers to reduce the time spent on developing foundational technologies, allowing them to focus on their actual research.

The software elements of BioMOBIUS™ provide:

  • Rapid Development (Graphical Development Environment)
  • Biosignal Processing Applications (Real Time)
  • Mobile hardware and physiological sensor support
  • Straightforward user interfaces (GUI Designer)
  • Reduced Development Replication (Re-use of Blocks)
  • Targeting applications

The BioMOBIUS Research Platform was developed by the TRIL Centre, a groundbreaking research collaboration between Intel Corporation and a number of Irish academic partners, and jointly funded by Intel and the Industrial Development Agency (IDA) Ireland. Its goal is to explore technology to help older people to continue living independently. The platform is being used primarily by TRIL researchers to help clinicians detect and prevent or alleviate certain conditions related to ageing, such as falls and cognitive decline, and to help older people to strengthen their social connections.

The hardware elements of the BioMOBIUS™ research platform provide support for the SHIMMER wireless sensor platform and other third party hardware and sensor devices.

BioMOBIUS™ is freely available to users for research purposes only. Please follow the links to the register and download pages to obtain a copy of the BioMOBIUS™ software environment. Details on hardware support and availability can be found in the hardware section. Please feel to share your experiences of MOBIUS and suggestions for enhancements and new features via the provided discussion forum.

For further information, please visit:
http://biomobius.trilcentre.org

Related news articles:

About the TRIL Centre
The TRIL Centre is a multi-million euro research collaboration between industry and academic partners including Intel, University College Dublin, Trinity College Dublin and the National University of Ireland, Galway. The Centre has created dedicated laboratories at Intel and in each of the universities involved, and is driving bi-directional knowledge and technology transfer of research that addresses the physical, cognitive and social consequences of ageing. The TRIL Centre is one of the largest research projects of its kind in the world. It will develop innovative technologies to help people 'age in place' wherever they choose to live. For more information, please visit www.trilcentre.org.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...